CABEI has disbursed US$18.1 million to purchase COVID-19 vaccines in Honduras
The figure represents 51.7% of the total funding granted for the implementation of the National Vaccine Introduction Plan.
Tegucigalpa, September 29, 2021.- More than 1.9 million doses for the benefit of more than 962,000 Hondurans have been acquired with disbursements made by the Central American Bank for Economic Integration (CABEI), the third for US$5.3 million as part of the financing to support the implementation of the National Plan for the Introduction of the COVID-19 Vaccine in Honduras.
This operation, for a total of US$35 million, will enable the acquisition of 2.8 million vaccines against COVID-19, which will be used to vaccinate 1.4 million people with two doses each.
CABEI Executive President, Dr. Dante Mossi, highlighted: "We are pleased to learn of the level of progress of this initiative, which with this third disbursement reaches more than half of its execution (51.7%) to support Honduras in its effort to save lives through sustained vaccination in the National Plan, allowing for the promotion and generation of confidence for the country's economic reactivation".
The loan agreement is part of CABEI's COVID-19 Emergency Support and Preparedness and Economic Reactivation Program, which CABEI made available to its member countries for up to US$800 million on concessional terms.
Honduras was the second country to access resources from this program in March for the purchase of vaccines, and CABEI made the first disbursement in June for US$7 million and the second in August for US$5.8 million.